Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Hubei Zhenhua Chemical Co.,Ltd. (603067.SS)
Huangshi, CN
Hubei Zhenhua Chemical Co.,Ltd. primarily conducts its operations within China, specializing in the entire lifecycle of chromium salt products, from their development and manufacturing to their ultimate sale and distribution. Their comprehensive product portfolio includes a wide array of chromium-based compounds such as sodium bichromate, various forms of chromic acid anhydride (both crystalline and liquid), chrome oxide green, and potassium dichromate. Beyond these core offerings, the company also supplies vitamin K3, anhydrous sodium sulphate, and aluminium hydroxide. The firm boasts an international presence, exporting its goods to diverse global markets across Europe, the United States, Africa, and Southeast Asia. Established in 1967, Hubei Zhenhua Chemical Co.,Ltd. is headquartered in Huangshi, China, and was previously known as Huanghsi Zhenhua Chemical Industry Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.60% | -6.84% | +7.80% | +2.46% | +44.55% | +21.42% | +120.00% | +316.92% | +557.52% | +986.34% | +986.34% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+11.5% ★ Q1'26: +17.1% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-3.3% Q1'26: -27.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+2.6% ★ Q1'26: -14.3% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+17.3% ★ Q1'26: +13.2% (vs Q1'25)
-
ROIC Chemicals: +3.4%+15.6% ★ Q1'26: +11.2% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+44.1% Q1'26: +42.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×0.94× Q1'26: 1.80× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.42B
est: 1.55B (-8.5%)
|
1.28B
est: 1.30B (-1.4%)
|
2.99B
est: 3.11B (-3.8%)
|
3.53B
est: 3.24B (+9.1%)
|
3.70B
est: 3.98B (-7.1%)
|
4.07B
est: 3.95B (+2.9%)
|
4.54B
est: 4.62B (-1.8%)
|
5.01B
5.01B – 5.01B
+8.5% YoY
|
5.31B
5.31B – 5.31B
+5.9% YoY
|
| EBITDA |
226.63M
est: 294.04M (-22.9%)
|
245.70M
est: 245.73M (0.0%)
|
551.17M
est: 589.21M (-6.5%)
|
709.80M
est: 613.65M (+15.7%)
|
655.29M
est: 754.27M (-13.1%)
|
784.60M
est: 748.74M (+4.8%)
|
1.03B
est: 874.91M (+17.8%)
|
949.56M
949.56M – 949.56M
+8.5% YoY
|
1.01B
1.01B – 1.01B
+5.9% YoY
|
| EBIT |
150.87M
est: 209.68M (-28.1%)
|
168.57M
est: 175.23M (-3.8%)
|
386.39M
est: 420.18M (-8.0%)
|
521.37M
est: 437.61M (+19.1%)
|
460.69M
est: 537.88M (-14.4%)
|
579.48M
est: 533.94M (+8.5%)
|
785.97M
est: 623.92M (+26.0%)
|
677.15M
677.15M – 677.15M
+8.5% YoY
|
717.28M
717.28M – 717.28M
+5.9% YoY
|
| Net Income |
136.32M
est: 152.10M (-10.4%)
|
149.84M
est: 110.14M (+36.0%)
|
310.67M
est: 234.97M (+32.2%)
|
416.97M
est: 302.89M (+37.7%)
|
370.81M
est: 432.16M (-14.2%)
|
472.88M
est: 337.77M (+40.0%)
|
659.04M
est: 457.46M (+44.1%)
|
570.54M
570.54M – 570.54M
+24.7% YoY
|
657.92M
657.92M – 657.92M
+15.3% YoY
|
| SGA |
186.59M
est: 137.82M (+35.4%)
|
160.52M
est: 115.18M (+39.4%)
|
249.87M
est: 276.18M (-9.5%)
|
289.78M
est: 287.63M (+0.7%)
|
297.44M
est: 353.54M (-15.9%)
|
295.05M
est: 350.95M (-15.9%)
|
177.47M
est: 410.09M (-56.7%)
|
445.08M
445.08M – 445.08M
+8.5% YoY
|
471.45M
471.45M – 471.45M
+5.9% YoY
|
| EPS |
0.32
est: 0.30 (+8.1%)
|
0.35
est: 0.21 (+63.3%)
|
0.63
est: 0.46 (+37.8%)
|
0.83
est: 0.59 (+40.8%)
|
0.74
est: 0.84 (-12.0%)
|
0.94
est: 0.66 (+43.0%)
|
0.93
est: 0.89 (+4.5%)
|
1.11
1.11 – 1.11
+24.7% YoY
|
1.28
1.28 – 1.28
+15.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | VanEck Rare Earth and Strategic Metals UCITS ETF REMX.L | 2.70% | 35.33M | 0.59% |
| 2 | VanEck Rare Earth and Strategic Metals ETF REMX | 2.70% | 64.74M | 0.53% |
| 3 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.01% | 993.2K | 0.39% |
| 4 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 931.2K | 0.06% |
| 5 | Dimensional - Emerging Markets High Profitability ETF DEHP | 0.00% | 17.3K | 0.44% |
| 6 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 346.5K | 0.29% |
| 7 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 71.1K | 0.26% |
| 8 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 31.5K | 0.48% |
| 9 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 3.51M | 0.06% |
| 10 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 214.5K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Da Xue Shi | Deputy GM & Director | — | male |
| Fan Yang | CFO & Secretary of the Board | — | male |
| Fen Fen Zhou | Accounting Supervisor | — | — |
| Guilin Zhu | Deputy General Manager | — | male |
| Liangrong Cheng | Deputy General Manager | — | male |
| Qian Yan Chen | Deputy GM & Director | — | male |
| Yu Sheng Ke | GM & Director | — | male |
| Zun You Ke | Deputy GM & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603067.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
